Skip to content

Bioenergetic Technology

Using Bioenergetic Technology to heal our bodies and minds

Menu

  • Home
  • About us
  • Contact us

Mental Health Research Symposium in New York City on Oct. 25

Uncategorized behavior, behavior-research, brain, city-on-oct, foundation, health, iscoveries-at-the, leading, mental-health, present-cutting-edge, research-symposium, symposium

( Brain & Behavior Research Foundation ) Leading researchers to present cutting-edge discoveries at the Brain & Behavior Research Foundation Mental Health Research Symposium in New York City on Oct.

Follow this link:
Mental Health Research Symposium in New York City on Oct. 25

Related posts:

  1. Leading Researchers to Present Cutting-Edge Discoveries at the Brain & Behavior Research Foundation Mental Health …
  2. Researchers create experimental blood test to determine BHI by gauging performance of mitochondria
  3. Faster, Easier, Better Results
  4. Seahorse Bioscience Announces AACR Travel Award Recipients
  • ← Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation of CPI-613 for Treatment of Myelodysplastic Syndrome
  • Leading Researchers to Present Cutting-Edge Discoveries at the Brain & Behavior Research Foundation Mental Health … →

Recent Posts

  • Reata gets FDA orphan drug status for bardoxolone methyl to treat PAH
  • New Subtle Energy Pattern Research Shows Increases in Cell Growth and Viability
  • Cornerstone Pharmaceuticals' CPI-613 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting …
  • Cornerstone Pharmaceuticals Announces Positive Phase I Data for CPI-613 in Relapsed or Refractory AML Patients to be …
  • Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Hodgkin's or T-Cell Non …
Copyright © 2025 Bioenergetic Technology. All rights reserved.
Theme: Accelerate by ThemeGrill. Powered by WordPress.